Page 4 - Lipid Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lipid management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lipid Management Today - Breaking & Trending Today

Esperion Therapeutics CEO steps down; COO promoted to top role

Esperion Therapeutics Inc. has appointed Sheldon Koenig to be its new president and CEO, succeeding Tim Mayleben, who has served in the role for a decade.The Ann Arbor-based pharmaceutical company said in a Monday morning news release that Koenig's appointment as the top executive for the company… ....

Tim Mayleben , Sheldon Koenig , Esperion Therapeutics Inc , Esperion Therapeutics , Ann Arbor Based , Lipid Management , ஷெல்டன் க்க்நிக் , ஆண்டு ஆர்பர் அடிப்படையிலானது , கொழுமியம் மேலாண்மை ,

Simulation Model based on Pooled Phase 3 Data Demonstrating


Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet’s Potential to Lower Absolute Cardiovascular Event Risk Presented at ACC.21
May 15, 2021 12:00 ET
| Source:
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.
Ann Arbor, Michigan, UNITED STATES
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction in 10-year cardiovascular event risk compared with statins alone (p ....

United States , United Kingdom , City Of , Kaitlyn Brosco , Gunn Laura , Daiichi Sankyo Europe , Nicholls Stephen , Laurah Gunn , Honorary Research , University Of North Carolina At Charlotte , American College Of Cardiology , Department Of Public Health Sciences , School Of Public Health , Lipid Management Company , Exchange Commission , Imperial College London , European Medicines Agency , Heart British Cardiac Society , School Of Data Science , Second Manifestations , Cholesterol Treatment Trialist , American College , Annual Scientific Session , Cardiovascular Benefits , Bempedoic Acid , Patients With Established Cardiovascular Disease ,